Back

In Situ Detection of α-Synuclein Seeding Activity Using Quiescent Seed Amplification Assay

Mao, H.; Kuang, Y.; Dai, W.; Lin, H.; Xu, P.

2025-03-26 neuroscience
10.1101/2025.03.26.645411 bioRxiv
Show abstract

The prion-like propagation of proteopathic -synuclein (Syn) "seeds" is a central pathogenic mechanism in synucleinopathies. However, methods to directly visualize this "seeding activity" within intact tissue are lacking. Conventional antibody-based techniques provide only static snapshots of pathological deposits, while sensitive seed amplification assays lose spatial information via mechanical fragmentation. Here, we introduce the Syn Quiescent Seed Amplification Assay (QSAA), a method for specific, robust, in situ amplification of Syn seeds directly within tissue sections. QSAA demonstrates superior sensitivity and earlier detection than pS129 and ThS staining, revealing widespread seeding in a PD mouse model, and successfully identifies endogenous seeds in archival human brains. By integrating with immunofluorescence, IF-QSAA uncovered microglial seeding activity and established that pS129 phosphorylation and seeding activity represent distinct pathological states. This offers unprecedented spatial insights into synucleinopathy pathogenesis, holding significant promises for early diagnosis and therapeutic evaluation.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
npj Parkinson's Disease
○ 105 papers in training set
Top 0.2%
12.7%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 16%
11.7%
Similar papers in this journal
3
Molecular Neurodegeneration
○ 55 papers in training set
Top 0.3%
6.2%
Similar papers in this journal
4
Cell Reports Methods
○ 165 papers in training set
Top 0.3%
5.1%
Similar papers in this journal
5
Advanced Science
○ 286 papers in training set
Top 1%
4.8%
Similar papers in this journal
6
Brain
◐ 168 papers in training set
Top 0.9%
4.3%
7
Communications Biology
○ 993 papers in training set
Top 4%
4.0%
8
Acta Neuropathologica Communications
○ 89 papers in training set
Top 0.7%
3.2%
50% of probability mass above
9
eLife
● 5828 papers in training set
Top 38%
3.1%
10
Acta Neuropathologica
○ 58 papers in training set
Top 0.5%
3.1%
11
Cell Reports
○ 1498 papers in training set
Top 14%
2.6%
12
Neuropathology and Applied Neurobiology
○ 15 papers in training set
Top 0.1%
2.6%
13
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 21%
2.4%
14
ACS Chemical Neuroscience
● 67 papers in training set
Top 0.5%
2.4%
15
Science Advances
● 1243 papers in training set
Top 17%
2.1%
16
Journal of Neurochemistry
○ 53 papers in training set
Top 0.5%
1.9%
17
Neurobiology of Disease
○ 148 papers in training set
Top 2%
1.9%
18
Molecular Therapy
○ 81 papers in training set
Top 0.8%
1.9%
19
Scientific Reports
○ 3612 papers in training set
Top 53%
1.7%
20
iScience
○ 1154 papers in training set
Top 20%
1.7%
21
Translational Neurodegeneration
○ 10 papers in training set
Top 0.1%
1.4%
22
Alzheimer's & Dementia
177 papers in training set
Top 2%
1.3%
23
Journal of Biological Chemistry
○ 690 papers in training set
Top 8%
1.1%
24
EMBO Molecular Medicine
○ 95 papers in training set
Top 2%
1.1%
25
Neuron
○ 337 papers in training set
Top 4%
1.1%
26
PLOS Biology
● 486 papers in training set
Top 14%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.